P. Samadi

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
P. Samadi, Pershia Samadi
Publication record
30 papers · 1,243 citations · H-index 20

PAPERS

The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out mice.
20198 citationsauthor #11
Effect of Anisum on improvement of clinical symptoms of Irritable bowel syndrome
20161 citationsauthor #5
Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease.
201564 citationsauthor #16
The effect of striatal pre‐enkephalin overexpression in the basal ganglia of the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson's disease
201412 citationsauthor #7
Striatal Pre-Enkephalin Overexpression Improves Huntington’s Disease Symptoms in the R6/2 Mouse Model of Huntington’s Disease
201329 citationsauthor #5
Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
201320 citationsauthor #3
Effect of chronic l-DOPA treatment on 5-HT(1A) receptors in parkinsonian monkey brain.
201220 citationsauthor #5
BDNF levels are not related with levodopa‐induced dyskinesias in MPTP monkeys
20109 citationsauthor #1
Effect of l‐Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys
201039 citationsauthor #5
Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
201047 citationsauthor #2
Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys.
201046 citationsauthor #2
Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys.
200994 citationsauthor #2
Implication of NMDA Receptors in the Antidyskinetic Activity of Cabergoline, CI-1041, and Ro 61-8048 in MPTP Monkeys with Levodopa-induced Dyskinesias
200947 citationsauthor #5
Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid.
200937 citationsauthor #2
Metabotropic Glutamate Receptor II in the Brains of Parkinsonian Patients
200933 citationsauthor #1
Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L‐dopa‐induced dyskinesias in MPTP parkinsonian monkeys
200812 citationsauthor #1
mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys.
2008124 citationsauthor #1
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.
200885 citationsauthor #4
Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias.
200853 citationsauthor #1
Functional neurochemistry of the basal ganglia.
200718 citationsauthor #1
Opioids and motor complications in Parkinson's disease.
200665 citationsauthor #1
Docosahexaenoic acid reduces levodopa‐induced dyskinesias in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine monkeys
2006111 citationsauthor #1
Dyskinesias occur in response to saline and naltrexone alone after priming with combination of dopaminergic agents and naltrexone in the MPTP parkinsonian monkeys.
200510 citationsauthor #1
Naltrexone in the short-term decreases antiparkinsonian response to l-Dopa and in the long-term increases dyskinesias in drug-naïve parkinsonian monkeys.
200517 citationsauthor #1
Effect of kynurenine 3‐hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in parkinsonian monkeys
200548 citationsauthor #1
The opioid agonist morphine decreases the dyskinetic response to dopaminergic agents in parkinsonian monkeys.
200446 citationsauthor #1
Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms.
200461 citationsauthor #6
Effect of antipsychotics on microglia in vitro
20040 citationsauthor #2
Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems.
200365 citationsauthor #1
Nicotine potentiation of morphine-induced catalepsy in mice.
200220 citationsauthor #2

TIMELINE

2002 20 citations

2003 65 citations

2004 107 citations

2005 75 citations

2006 176 citations

2007 18 citations

2008 274 citations

2009 211 citations

2010 141 citations

2012 20 citations

2013 49 citations

2014 12 citations

2015 64 citations

2016 1 citations

2019 8 citations

P. Samadi

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT